Get started
Author

Anastasiia S Zykova

Observed names: A S Zykova, A Zykova, A. S. Zykova, A. Zykova, A.S. ZYKOVA, A.S. Zykova, ANASTASIIA ZYKOVA, Anastasiia Zykova
ORCID: 0000-0002-7674-8643
Observed ORCID: 0000-0002-7674-8643
OpenAlex ID: A5088048652
The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis
2020 · S Moiseev, J M Lee, et al. · Clinical & Experimental Immunology · 75
PDF
Clinical characteristics of 1007 intensive care unitpatients with SARS-CoV-2 pneumonia
2020 · P. Glybochko, V. Fomin, et al. · Clinical pharmacology and therapy · 58
PDF
Testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with systemic vasculitides and other diseases
2016 · Pavel Novikov, Ilya Smitienko, et al. · Annals of the Rheumatic Diseases · 18
PDF
Efficacy of tocilizumab in the intensive care unit patients with COVID-19: a retrospective cohort study
2020 · S.V. Moiseev, S.N. Avdeev, et al. · Clinical pharmacology and therapy · 15
PDF
Neither earlier nor late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study
2020 · Sergey Moiseev, Sergey Avdeev, et al. · Annals of the Rheumatic Diseases · 15
Risk factors for the early development of septic shock in patients with severe COVID-19
2020 · P. V. Glybochko, V. V. Fomin, et al. · Terapevticheskii arkhiv · 13
PDF
Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides
2018 · N M Bulanov, E A Makarov, et al. · Terapevticheskii arkhiv · 11
PDF
Prognostic value of renal resistance index in estimating the progression of chronic kidney disease
2015 · V. E. Gazhonova, A. S. Zykova, et al. · Terapevticheskii arkhiv · 7
Kidney Pathology and Outcomes in ANCA-Associated Vasculitis: Retrospective Analysis of 85 Patients
2021 · Elena Zakharova, Anastasiia Zykova, et al. · Kidney and Dialysis · 5
PDF
Assessing Cardiovascular Risk in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Comment on the Article by Wallace et al
2019 · Sergey Moiseev, Pavel Novikov, et al. · Arthritis & Rheumatology · 5
Rituximab in ANCA-associated vasculitis: fewer infusions or ultra low-dose maintenance therapy?
2018 · Sergey V Moiseev, Nikolai M Bulanov, et al. · Annals of the Rheumatic Diseases · 5
The modern therapy of systemic vasculitides: perspectives and challenges
2018 · P.I. NOVIKOV, A.S. ZYKOVA, et al. · Terapevticheskii arkhiv · 5
ANCA-positive and ANCA-negative granulomatosis with polyangiitis
2020 · I.G. Smirnova, N.M. Bulanov, et al. · Clinical pharmacology and therapy · 4
PDF
Clinical and pathology characteristics of 197 patients with monoclonal gammopathies of renal significance and paraprotein-related kidney damage in malignant lymphoproliferative disorders
2024 · E.V. Zakharova, A.S. Zykova, et al. · Nephrology and Dialysis · 3
PDF
C3 glomerulopathy: a long way from the light microscopy findings to the targeted therapy
2023 · E.V. Zakharova, A.S. Zykova · Nephrology and Dialysis · 3
PDF
Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine
2018 · Pavel I Novikov, Nikolai M Bulanov, et al. · Annals of the Rheumatic Diseases · 3
Tofacitinib versus standard of care treatment in patients with COVID-19: a multicenter non-randomized controlled study
2021 · Sergey Moiseev, Nikolay Bulanov, et al. · 2
PDF
Glomerular Hyperfiltration or Microalbuminuria as an Early Marker of Fabry Nephropathy
2019 · Sergey Moiseev, Ekaterina Karovaikina, et al. · The Nephron journals/Nephron journals · 2
[Antipsychotic drugs and their influence on the carbohydrate metabolism in patients with schizophrenia-spectrum disorders].
2014 · B D Tsygankov, E G Agasarain, et al. · PubMed · 2
Complement activation in ANCA-associated vasculitis
2020 · A. Zykova, N. Bulanov, et al. · Clinical pharmacology and therapy · 1
PDF
Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis
2020 · P.I. Novikov, N.M. Bulanov, et al. · Clinical pharmacology and therapy · 1
PDF
Is There a Role for LAMP-2 Autoantibodies in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis?
2020 · SERGEY MOISEEV, ANASTASIIA ZYKOVA, et al. · The Journal of Rheumatology · 1
PDF
328. Atypical Hemolytic Uremic Syndrome Associated With Diacylglycerol Kinase-e Mutation in a Patient With Microscopic Polyangiitis: a Possible Relationship Via Complement Activation?
2019 · Nikolai Bulanov, Elena Shchegoleva, et al. · Rheumatology · 1
Complement in ANCA-associated vasculitis: from pathogenesis to treatment
2019 · A.S. Zykova, E.S. Vinogradova, et al. · Clinical pharmacology and therapy · 1
PDF
SAT0529 Short-term efficacy and safety of biosimilar rituximab in patients with systemic vasculitides
2018 · I. Smitienko, P. Novikov, et al. · Annals of the Rheumatic Diseases · 1
PDF
Works count: 47
Citation count: 259
H-index: 7
I10-index: 7
Year
Topic
Type